Skip to main content
Erschienen in: Archives of Dermatological Research 6/2023

14.12.2022 | REVIEW

Clinical characteristics and treatment outcomes of Pityrosporum folliculitis in immunocompetent patients

verfasst von: Maxwell Green, Aileen M. Feschuk, Nadia Kashetsky, Howard I. Maibach

Erschienen in: Archives of Dermatological Research | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Pityrosporum folliculitis (PF) is a fungal acneiform disease of the hair follicles that often presents with pruritic papules and pustules on the upper body and face. This condition is commonly mistaken for acne vulgaris and can be distinguished from bacterial acne by the presence of fungal spores in the follicular lumen. Although studies have been performed to describe PF in cohorts, little work has been done to aggregate these data. Thus, the goal of this review is to describe the clinical characteristics and treatment outcomes of PF in immunocompetent patients. PubMed, Web of Science, and Embase were searched using the terms “Pityrosporum folliculitis” or “Malassezia folliculitis.” All cohorts reporting PF characteristics in patients classified as immunocompetent were reviewed. A total of 15 studies were included. Majority of patients were male (64%) with the average age of presentation of 24.26 years. The most common locations of lesions were the chest (70%) and back/shoulders (69.2%). Pruritus was reported by the majority of patients (71.7%). Additionally, 40.5% of patients reported a history of unsuccessful treatment regimens. Treatment was most successful with an oral antifungal (92%), followed by a topical antifungal (81.6%). In conclusion, majority of patients with PF were younger males. Many patients were primarily treated incorrectly, suggesting the importance of proper diagnosis. PF may be distinguishable from acne vulgaris by the presence of pruritus or suggested when a new acneiform eruption develops following antibiotic therapy or immunosuppression. When properly diagnosed, majority of cases of PF achieve complete response with oral or topical antifungals.
Literatur
1.
Zurück zum Zitat Abdel-Razek M, Fadaly G, Abdel-Raheim M, Al-Morsy F (1995) Pityrosporum (Malassezia) folliculitis in Saudi Arabia–diagnosis and therapeutic trials. Clin Exp Dermatol. 20(5):406–409CrossRefPubMed Abdel-Razek M, Fadaly G, Abdel-Raheim M, Al-Morsy F (1995) Pityrosporum (Malassezia) folliculitis in Saudi Arabia–diagnosis and therapeutic trials. Clin Exp Dermatol. 20(5):406–409CrossRefPubMed
2.
Zurück zum Zitat Ayers K, Sweeney SM, Wiss K (2005) Pityrosporum folliculitis: diagnosis and management in 6 female adolescents with acne vulgaris. Arch Pediatr Adolesc Med 159(1):64–67CrossRefPubMed Ayers K, Sweeney SM, Wiss K (2005) Pityrosporum folliculitis: diagnosis and management in 6 female adolescents with acne vulgaris. Arch Pediatr Adolesc Med 159(1):64–67CrossRefPubMed
3.
Zurück zum Zitat Bäck O, Faergemann J, Hörnqvist R (1985) Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol 12(1 Pt 1):56–61CrossRefPubMed Bäck O, Faergemann J, Hörnqvist R (1985) Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol 12(1 Pt 1):56–61CrossRefPubMed
4.
Zurück zum Zitat Corzo-León DE, MacCallum DM, Munro CA (2020) Host responses in an. Front Cell Infect Microbiol 10:561382CrossRefPubMed Corzo-León DE, MacCallum DM, Munro CA (2020) Host responses in an. Front Cell Infect Microbiol 10:561382CrossRefPubMed
5.
Zurück zum Zitat Danby FW (2016) Malassezia infections-Management with pulsed oral ketoconazole. J Am Acad Dermatol 74(5): AB159 Danby FW (2016) Malassezia infections-Management with pulsed oral ketoconazole. J Am Acad Dermatol 74(5): AB159
6.
Zurück zum Zitat Del Rosso JQ, Silverberg N, Zeichner JA (2016) When acne is not acne. Dermatol Clin 34(2):225–228CrossRefPubMed Del Rosso JQ, Silverberg N, Zeichner JA (2016) When acne is not acne. Dermatol Clin 34(2):225–228CrossRefPubMed
7.
Zurück zum Zitat Durdu M, Güran M, Kandemir H, Ilkit M, Seyedmousavi S (2016) Clinical and laboratory features of six cases of candida and dermatophyte folliculitis and a review of published studies. Mycopathologia 181(1–2):97–105CrossRefPubMed Durdu M, Güran M, Kandemir H, Ilkit M, Seyedmousavi S (2016) Clinical and laboratory features of six cases of candida and dermatophyte folliculitis and a review of published studies. Mycopathologia 181(1–2):97–105CrossRefPubMed
8.
Zurück zum Zitat Gupta AK, Lyons DC (2015) The rise and fall of oral ketoconazole. J Cutan Med Surg. 19(4):352–357CrossRefPubMed Gupta AK, Lyons DC (2015) The rise and fall of oral ketoconazole. J Cutan Med Surg. 19(4):352–357CrossRefPubMed
9.
Zurück zum Zitat Hald M, Arendrup MC, Svejgaard EL, Lindskov R, Foged EK (2015) Danish society of dermatology. Evidence-based danish guidelines for the treatment of malassezia-related skin diseases. Acta Derm Venereol 95(1):12–19CrossRefPubMed Hald M, Arendrup MC, Svejgaard EL, Lindskov R, Foged EK (2015) Danish society of dermatology. Evidence-based danish guidelines for the treatment of malassezia-related skin diseases. Acta Derm Venereol 95(1):12–19CrossRefPubMed
10.
Zurück zum Zitat Hill MK, Goodfield MJ, Rodgers FG, Crowley JL, Saihan EM (1990) Skin surface electron microscopy in Pityrosporum folliculitis. The role of follicular occlusion in disease and the response to oral ketoconazole. Arch Dermatol 126(8):1071–1074CrossRefPubMed Hill MK, Goodfield MJ, Rodgers FG, Crowley JL, Saihan EM (1990) Skin surface electron microscopy in Pityrosporum folliculitis. The role of follicular occlusion in disease and the response to oral ketoconazole. Arch Dermatol 126(8):1071–1074CrossRefPubMed
11.
Zurück zum Zitat Kim S, Park JW, Yeon Y, Han JY, Kim E (2019) Influence of exposure to summer environments on skin properties. J Eur Acad Dermatol Venereol 33(11):2192–2196CrossRefPubMed Kim S, Park JW, Yeon Y, Han JY, Kim E (2019) Influence of exposure to summer environments on skin properties. J Eur Acad Dermatol Venereol 33(11):2192–2196CrossRefPubMed
12.
Zurück zum Zitat Lim KB, Giam YC, Tan T (1987) The epidemiology of Malassezia (Pityrosporon) folliculitis in Singapore. Int J Dermatol 26(7):438–441CrossRefPubMed Lim KB, Giam YC, Tan T (1987) The epidemiology of Malassezia (Pityrosporon) folliculitis in Singapore. Int J Dermatol 26(7):438–441CrossRefPubMed
13.
Zurück zum Zitat Lévy A, Feuilhade de Chauvin M, Dubertret L, Morel P, Flageul B (2007) Folliculites à Malassezia: Caractéristiques et réponses thérapeutiques chez 26 malades [Malassezia folliculitis: characteristics and therapeutic response in 26 patients]. Ann Dermatol Venereol 134(11):823–828CrossRefPubMed Lévy A, Feuilhade de Chauvin M, Dubertret L, Morel P, Flageul B (2007) Folliculites à Malassezia: Caractéristiques et réponses thérapeutiques chez 26 malades [Malassezia folliculitis: characteristics and therapeutic response in 26 patients]. Ann Dermatol Venereol 134(11):823–828CrossRefPubMed
14.
Zurück zum Zitat Luebberding S, Krueger N, Kerscher M (2013) Skin physiology in men and women: in vivo evaluation of 300 people including TEWL, SC hydration, sebum content and skin surface pH. Int J Cosmet Sci 35(5):477–483CrossRefPubMed Luebberding S, Krueger N, Kerscher M (2013) Skin physiology in men and women: in vivo evaluation of 300 people including TEWL, SC hydration, sebum content and skin surface pH. Int J Cosmet Sci 35(5):477–483CrossRefPubMed
15.
Zurück zum Zitat Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol (Engl Ed) 74(9):790–799CrossRefPubMed Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol (Engl Ed) 74(9):790–799CrossRefPubMed
16.
Zurück zum Zitat Parsad D, Saini R, Negi KS (1998) Short-term treatment of pityrosporum folliculitis: a double blind placebo-controlled study. J Eur Acad Dermatol Venereol 11(2):188–190CrossRefPubMed Parsad D, Saini R, Negi KS (1998) Short-term treatment of pityrosporum folliculitis: a double blind placebo-controlled study. J Eur Acad Dermatol Venereol 11(2):188–190CrossRefPubMed
17.
Zurück zum Zitat Peres FLX, Bonamigo RR, Bottega GB, Staub FL, Cartell AS, Bakos RM (2022) Pityrosporum folliculitis in critically ill COVID-19 patients. J Eur Acad Dermatol Venereol 36(3):e186–e188CrossRefPubMed Peres FLX, Bonamigo RR, Bottega GB, Staub FL, Cartell AS, Bakos RM (2022) Pityrosporum folliculitis in critically ill COVID-19 patients. J Eur Acad Dermatol Venereol 36(3):e186–e188CrossRefPubMed
18.
Zurück zum Zitat Piquero-Casals J, Hexsel D, Mir-Bonafé JF, Rozas-Muñoz E (2019) Topical non-pharmacological treatment for facial seborrheic dermatitis. Dermatol Ther (Heidelb) 9(3):469–477CrossRefPubMed Piquero-Casals J, Hexsel D, Mir-Bonafé JF, Rozas-Muñoz E (2019) Topical non-pharmacological treatment for facial seborrheic dermatitis. Dermatol Ther (Heidelb) 9(3):469–477CrossRefPubMed
19.
Zurück zum Zitat Prindaville B, Belazarian L, Levin NA, Wiss K (2018) Pityrosporum folliculitis: a retrospective review of 110 cases. J Am Acad Dermatol. 78(3):511–514CrossRefPubMed Prindaville B, Belazarian L, Levin NA, Wiss K (2018) Pityrosporum folliculitis: a retrospective review of 110 cases. J Am Acad Dermatol. 78(3):511–514CrossRefPubMed
20.
Zurück zum Zitat Pürnak S, Durdu M, Tekindal MA, Güleç AT, Seçkin D (2018) The prevalence of. Skinmed. 16(2):99–104PubMed Pürnak S, Durdu M, Tekindal MA, Güleç AT, Seçkin D (2018) The prevalence of. Skinmed. 16(2):99–104PubMed
21.
Zurück zum Zitat Ran YP, Zhou GP (1988) Pityrosporum folliculitis. Clinical and pathologic report of seven cases. Chin Med J (Engl). 101(10):748–749PubMed Ran YP, Zhou GP (1988) Pityrosporum folliculitis. Clinical and pathologic report of seven cases. Chin Med J (Engl). 101(10):748–749PubMed
22.
23.
Zurück zum Zitat Suzuki C, Hase M, Shimoyama H, Sei Y (2016) Treatment outcomes for malassezia folliculitis in the dermatology department of a University Hospital in Japan. Med Mycol J 57(3):E63-66CrossRefPubMed Suzuki C, Hase M, Shimoyama H, Sei Y (2016) Treatment outcomes for malassezia folliculitis in the dermatology department of a University Hospital in Japan. Med Mycol J 57(3):E63-66CrossRefPubMed
24.
Zurück zum Zitat Tsai YC, Wang JY, Wu YH, Wang YJ (2018) Atypical clinical presentations of Malassezia folliculitis: a retrospective analysis of 94 biopsy-proven cases. Int J Dermatol. 57(3):e19–e20 Tsai YC, Wang JY, Wu YH, Wang YJ (2018) Atypical clinical presentations of Malassezia folliculitis: a retrospective analysis of 94 biopsy-proven cases. Int J Dermatol. 57(3):e19–e20
25.
Zurück zum Zitat Tsai YC, Wang JY, Wu YH, Wang YJ (2019) Clinical differences in pediatric and adult Malassezia folliculitis: Retrospective analysis of 321 cases over 9 years. J Am Acad Dermatol. 81(1):278–280CrossRefPubMed Tsai YC, Wang JY, Wu YH, Wang YJ (2019) Clinical differences in pediatric and adult Malassezia folliculitis: Retrospective analysis of 321 cases over 9 years. J Am Acad Dermatol. 81(1):278–280CrossRefPubMed
26.
Zurück zum Zitat Tu WT, Chin SY, Chou CL et al (2018) Utility of Gram staining for diagnosis of Malassezia folliculitis. J Dermatol 45(2):228–231CrossRefPubMed Tu WT, Chin SY, Chou CL et al (2018) Utility of Gram staining for diagnosis of Malassezia folliculitis. J Dermatol 45(2):228–231CrossRefPubMed
27.
Zurück zum Zitat Vest BE, Krauland K (2022) Malassezia Furfur. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing Vest BE, Krauland K (2022) Malassezia Furfur. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing
29.
Zurück zum Zitat Xu X, Ran X, Tang J et al (2021) Skin microbiota in non-inflammatory and inflammatory lesions of acne vulgaris: the underlying changes within the Pilosebaceous unit. Mycopathologia 186(6):863–869CrossRefPubMed Xu X, Ran X, Tang J et al (2021) Skin microbiota in non-inflammatory and inflammatory lesions of acne vulgaris: the underlying changes within the Pilosebaceous unit. Mycopathologia 186(6):863–869CrossRefPubMed
30.
Zurück zum Zitat Yong AM, Tan SY, Tan CL (2021) An update on pityrosporum folliculitis in Singapore from a single tertiary care dermatological centre. Singapore Med J. 62(10):526–528CrossRefPubMedPubMedCentral Yong AM, Tan SY, Tan CL (2021) An update on pityrosporum folliculitis in Singapore from a single tertiary care dermatological centre. Singapore Med J. 62(10):526–528CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Yu HJ, Lee SK, Son SJ, Kim YS, Yang HY, Kim JH (1998) Steroid acne vs. Pityrosporum folliculitis: the incidence of Pityrosporum ovale and the effect of antifungal drugs in steroid acne. Int J Dermatol. 37(10):772–777CrossRefPubMed Yu HJ, Lee SK, Son SJ, Kim YS, Yang HY, Kim JH (1998) Steroid acne vs. Pityrosporum folliculitis: the incidence of Pityrosporum ovale and the effect of antifungal drugs in steroid acne. Int J Dermatol. 37(10):772–777CrossRefPubMed
Metadaten
Titel
Clinical characteristics and treatment outcomes of Pityrosporum folliculitis in immunocompetent patients
verfasst von
Maxwell Green
Aileen M. Feschuk
Nadia Kashetsky
Howard I. Maibach
Publikationsdatum
14.12.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 6/2023
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-022-02506-0

Weitere Artikel der Ausgabe 6/2023

Archives of Dermatological Research 6/2023 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.